欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0527/002
药品名称Lecalpin
活性成分
    • lercanidipine hydrochloride 20.0 mg
剂型Film-coated tablet
上市许可持有人Accord Healthcare Ireland Ltd., Euro House, Euro Business Park, Little Island, Cork T45 K857, Ireland Splitting of procedure - DK/H/1490/001-002/DC (old procedure number) to IE/H/527/001-002/DC (new procedure number)
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Lecalpin
许可日期2017/09/30
最近更新日期2023/07/26
药物ATC编码
    • C08CA03 isradipine
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase